Senior insider sale
President & CEO at NEKTAR THERAPEUTICS — senior position signals high conviction
$261.2K
8.24K shares
ROBIN HOWARD W plans to sell 8.24K shares of NEKTAR THERAPEUTICS valued at approximately $261.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2019 | Restricted Stock Vesting Compensation | 474.00 | — |
2/15/2019 | Restricted Stock Vesting Compensation | 1.07K | — |
11/15/2018 | Restricted Stock Vesting Compensation | 1.01K | — |
8/15/2018 | Restricted Stock Vesting Compensation | 1.35K | — |
2/15/2018 | Restricted Stock Vesting Compensation | 190.00 | — |
11/15/2017 | Restricted Stock Vesting Compensation | 1.07K | — |
| Total | 5.17K | ||
Completed
Units to sell
1.50K
Market value
$45.2K
Units to sell
1.57K
Market value
$41.8K
Planned — Approximate Date
Units to sell
5.17K
Market value
$174.1K
Units
8.24K
Value
$261.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/2/2025 | 1.50K | $45.2K | — | Completed |
8/19/2025 | 1.57K | $41.8K | — | Completed |
| Planned — Approximate Date | ||||
9/4/2025 | 5.17K | $174.1K | NASDAQ | Planned |
| Total | 8.24K | $261.2K | ||